Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A7ER
|
||||
| Former ID |
DNC005904
|
||||
| Drug Name |
N-(tert-butoxycarbonyl)-norvalyl-glycine-nitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527885] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C12H21N3O3
|
||||
| Canonical SMILES |
CCCC(C(=O)NCC#N)NC(=O)OC(C)(C)C
|
||||
| InChI |
1S/C12H21N3O3/c1-5-6-9(10(16)14-8-7-13)15-11(17)18-12(2,3)4/h9H,5-6,8H2,1-4H3,(H,14,16)(H,15,17)/t9-/m0/s1
|
||||
| InChIKey |
PBHMIOPVNIIFHR-VIFPVBQESA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin S | Target Info | Inhibitor | [527885] | |
| Cathepsin K | Target Info | Inhibitor | [527885] | ||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Activation of Matrix Metalloproteinases | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.